Waning Tdap Effectiveness in Adolescents
- PMID: 26908667
- DOI: 10.1542/peds.2015-3326
Waning Tdap Effectiveness in Adolescents
Abstract
Background and objective: Because the effectiveness of diphtheria-tetanus-acellular pertussis (DTaP) vaccine wanes substantially after the fifth dose at ages 4 to 6 years, there is a growing cohort of adolescents who rely on tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) for protection against pertussis. Yet despite high Tdap vaccine coverage among adolescents, California experienced large pertussis outbreaks in 2010 and 2014. We investigated Tdap vaccine effectiveness (VE) and waning within Kaiser Permanente Northern California among adolescents exclusively vaccinated with DTaP vaccines.
Methods: We modeled pertussis risk in relation to Tdap vaccination status among adolescents beginning on their 10th birthday. We estimated the hazard ratio (HR) for each subsequent year after Tdap compared with unvaccinated adolescents by using Cox regression, adjusting for calendar time, age, gender, race, and facility. We calculated VE as 1 - HR. We also treated time since Tdap vaccination as a continuous variable and estimated the change in the HR per 1-year increase since vaccination.
Results: On the basis of 1207 pertussis cases, Tdap VE during the first year after vaccination was 68.8% (95% confidence interval [CI] 59.7% to 75.9%), decreasing to 8.9% (95% CI -30.6% to 36.4%) by ≥4 years after vaccination. Adolescents who were more remote from Tdap were significantly more likely to test positive for pertussis than were those vaccinated more recently (HR per year 1.35, 95% CI 1.22 to 1.50).
Conclusions: Routine Tdap did not prevent pertussis outbreaks. Among adolescents who have only received DTaP vaccines in childhood, Tdap provided moderate protection against pertussis during the first year and then waned rapidly so that litle protection remained 2-3 years after vaccination..
Copyright © 2016 by the American Academy of Pediatrics.
Similar articles
-
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34. MMWR Recomm Rep. 2006. PMID: 16557217
-
Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.Pediatrics. 2006 Mar;117(3):965-78. doi: 10.1542/peds.2005-3038. Epub 2005 Dec 28. Pediatrics. 2006. PMID: 16382131
-
Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand.J Infect Dis. 2014 Sep 15;210(6):942-53. doi: 10.1093/infdis/jiu322. Epub 2014 Jun 5. J Infect Dis. 2014. PMID: 24903664
-
Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2008 May 30;57(RR-4):1-51. MMWR Recomm Rep. 2008. PMID: 18509304 Review.
-
Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.Expert Rev Vaccines. 2008 Jul;7(5):621-34. doi: 10.1586/14760584.7.5.621. Expert Rev Vaccines. 2008. PMID: 18564017 Review.
Cited by
-
A multi-omics systems vaccinology resource to develop and test computational models of immunity.Cell Rep Methods. 2024 Mar 25;4(3):100731. doi: 10.1016/j.crmeth.2024.100731. Epub 2024 Mar 14. Cell Rep Methods. 2024. PMID: 38490204 Free PMC article.
-
Opposing effects of acellular and whole cell pertussis vaccines on Bordetella pertussis biofilm formation, Siglec-F+ neutrophil recruitment and bacterial clearance in mouse nasal tissues.bioRxiv [Preprint]. 2024 Jan 25:2024.01.23.576795. doi: 10.1101/2024.01.23.576795. bioRxiv. 2024. PMID: 38328073 Free PMC article. Preprint.
-
Comparative Evaluation of Recombinant and Acellular Pertussis Vaccines in a Murine Model.Vaccines (Basel). 2024 Jan 22;12(1):108. doi: 10.3390/vaccines12010108. Vaccines (Basel). 2024. PMID: 38276680 Free PMC article.
-
Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records.BMJ. 2023 Nov 8;383:e076321. doi: 10.1136/bmj-2023-076321. BMJ. 2023. PMID: 37940142 Free PMC article.
-
High post-exposure prophylaxis (PEP) uptake among household contacts of pertussis patients enrolled in a PEP effectiveness evaluation - United States, 2015-2017.PLoS One. 2023 May 18;18(5):e0285953. doi: 10.1371/journal.pone.0285953. eCollection 2023. PLoS One. 2023. PMID: 37200360 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical